James Investment Research Inc Natera, Inc. Transaction History

James Investment Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$86.26 - $119.0 $268,613 - $370,566	-3,114 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$100.17 - $126.36 $79,434 - $100,203	-793 Reduced 20.3%	3,114 $347,000
Q2 2021 Jul 26, 2021	BUY	$86.05 - $119.72 $76,842 - $106,909	893 Added 29.63%	3,907 $444,000
Q1 2021 Apr 22, 2021	BUY	$91.47 - $124.36 $229,864 - $312,516	2,513 Added 501.6%	3,014 $306,000
Q4 2020 Jan 27, 2021	BUY	$66.66 - $111.74 $33,396 - $55,981	501 New	501 $50,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.